Patent ID: 6333306
Filing Date: 2001-12-25
Classification: A61K,A61P,Y10S

Abstract:
A method for the treatment of hemodialysis patients or patients exhibiting anemia, comprising administering to a patient in need of such treatment effective amounts of erythropoietin and a physiologically tolerable iron preparation contained in a pharmaceutical combination preparation, wherein the pharmaceutical combination preparation contains about 2,000-7,000 U of erythropoietin and a quantity of iron preparation equivalent to about 1-20 mg of iron ions, wherein the erythropoietin and the iron preparation are administered both in the correction phase and the maintenance phase of iron therapy, wherein the iron doses are, independently, 1-20 mg/week in the correction phase and the maintenance phase and wherein the erythropoietin doses are, independently, up to 15,000 U/week in the correction phase and the maintenance phase.